BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37057967)

  • 1. Nanovaccines Fostering Tertiary Lymphoid Structure to Attack Mimicry Nasopharyngeal Carcinoma.
    Wen Z; Liu H; Qiao D; Chen H; Li L; Yang Z; Zhu C; Zeng Z; Chen Y; Liu L
    ACS Nano; 2023 Apr; 17(8):7194-7206. PubMed ID: 37057967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1
    Li JP; Wu CY; Chen MY; Liu SX; Yan SM; Kang YF; Sun C; Grandis JR; Zeng MS; Zhong Q
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34253636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8
    Wang M; Zhai R; Wang M; Zhu W; Zhang J; Yu M; Zhang W; Ye J; Liu L
    Mol Oncol; 2023 Aug; 17(8):1514-1530. PubMed ID: 36825382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
    Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
    BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.
    Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C
    J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients.
    Yin YX; Ling YH; Wei XL; He CY; Wang BZ; Hu CF; Lin WP; Nie RC; Chen JW; Lin JL; Zhou J; Xie JJ; Yun JP; Xie D; Xue LY; Cai MY
    Front Immunol; 2022; 13():973085. PubMed ID: 36591236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.
    Yamakoshi Y; Tanaka H; Sakimura C; Deguchi S; Mori T; Tamura T; Toyokawa T; Muguruma K; Hirakawa K; Ohira M
    Int J Oncol; 2020 Jul; 57(1):171-182. PubMed ID: 32319601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
    Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
    Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy.
    Jiang X; Wang J; Zheng X; Liu Z; Zhang X; Li Y; Wilhelm J; Cao J; Huang G; Zhang J; Sumer B; Lea J; Lu Z; Gao J; Luo M
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35623658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
    Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
    Front Immunol; 2021; 12():690105. PubMed ID: 34054879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Characterization of Tertiary Lymphoid Structures in Murine Melanoma.
    Rodriguez AB; Peske JD; Engelhard VH
    Methods Mol Biol; 2018; 1845():241-257. PubMed ID: 30141017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
    Chen J; Chen J; Wang L
    J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune cells markers within local tumor microenvironment are associated with EBV oncoprotein in nasopharyngeal cancer.
    Gondhowiardjo SA; Adham M; Rachmadi L; Atmakusuma TD; Tobing DL; Auzan M; Hariyanto AD; Sulaeman D; Permata TBM; Handoko
    BMC Cancer; 2022 Aug; 22(1):887. PubMed ID: 35963999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38/mitogen-activated protein kinase and NF-κB pathways: impairment in T cell functions.
    Liu WL; Lin YH; Xiao H; Xing S; Chen H; Chi PD; Zhang G
    J Virol; 2014 Jun; 88(12):6660-71. PubMed ID: 24696473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.
    Ling Y; Zhong J; Weng Z; Lin G; Liu C; Pan C; Yang H; Wei X; Xie X; Wei X; Zhang H; Wang G; Fu J; Wen J
    Clin Transl Med; 2022 Oct; 12(10):e1074. PubMed ID: 36245289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic nanovaccines sensitize EBV-associated tumors to checkpoint blockade therapy.
    Liu H; Chen H; Liu Z; Le Z; Nie T; Qiao D; Su Y; Mai H; Chen Y; Liu L
    Biomaterials; 2020 Oct; 255():120158. PubMed ID: 32544717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and Cellular Requirements for the Assembly of Tertiary Lymphoid Structures.
    Mueller CG; Nayar S; Campos J; Barone F
    Adv Exp Med Biol; 2018; 1060():55-72. PubMed ID: 30155622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.
    Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H
    Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas.
    Kinker GS; Vitiello GAF; Diniz AB; Cabral-Piccin MP; Pereira PHB; Carvalho MLR; Ferreira WAS; Chaves AS; Rondinelli A; Gusmão AF; Defelicibus A; Dos Santos GO; Nunes WA; Claro LCL; Bernardo TM; Nishio RT; Pacheco AM; Laus AC; Arantes LMRB; Fleck JL; de Jesus VHF; de Moricz A; Weinlich R; Coimbra FJF; de Lima VCC; Medina TDS
    Gut; 2023 Oct; 72(10):1927-1941. PubMed ID: 37230755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.